Employees: NN (None)Legal category: SCA (commandite par actions)Size: GECreation date: 1987-06-02 (38 years)Status: ActiveBusiness sector: Activités des sièges sociauxLocation: NANTES (44300), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS : revenue, balance sheet and financial ratios
EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS is a French company
founded 38 years ago,
specialized in the sector Activités des sièges sociaux.
Based in NANTES (44300),
this company of category GE
shows in 2024 a net income negative of -2.7 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS (SIREN 341561595)
Indicator
2024
2023
2022
2021
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
-2 674 494 €
-4 010 546 €
-1 999 895 €
1 606 662 €
1 422 220 €
2 011 556 €
-4 021 592 €
456 114 €
EBITDA
-29 733 €
-15 824 €
-25 181 €
753 €
-35 931 €
-116 380 €
-60 002 €
-279 555 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS records a net loss of 2.7 M€. This deficit will reduce equity on the balance sheet.
EBITDA (2024)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-29 733 €
EBIT (2024)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-29 733 €
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-2 674 494 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 26%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 78%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 11.8 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
26.313%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
78.384%
Repayment capacity (2024)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
11.752
Solvency indicators evolution EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
Debt ratio
0.046
0.008
0.0
0.0
51.197
44.641
50.918
26.313
Financial autonomy
94.488
95.32
72.547
71.622
64.9
66.389
65.684
78.384
Repayment capacity
0.042
0.004
0.0
0.0
3.653
4.982
13.146
11.752
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
26.312024
2022
2023
2024
Q1: 0.06
Med: 14.61
Q3: 89.57
Average
In 2024, the debt ratio of EUROFINS MICROBIOLOGIE FR... (26.31) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
78.38%2024
2022
2023
2024
Q1: 11.57%
Med: 51.97%
Q3: 85.24%
Good+9 pts over 3 years
In 2024, the financial autonomy of EUROFINS MICROBIOLOGIE FR... (78.4%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
11.75 years2024
2022
2023
2024
Q1: 0.0 years
Med: 0.2 years
Q3: 3.73 years
Average
In 2024, the repayment capacity of EUROFINS MICROBIOLOGIE FR... (11.75) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 750.16. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
750.164
Interest coverage (2024)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-13186.392
Liquidity indicators evolution EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
Liquidity ratio
42.254
26.136
18.213
12.411
699.552
726.03
2329.148
750.164
Interest coverage
-0.604
-9189.749
-154.025
-891.548
396666.268
-36603.451
-36615.508
-13186.392
Sector positioning
Liquidity ratio
750.162024
2022
2023
2024
Q1: 116.63
Med: 458.65
Q3: 2184.57
Good
In 2024, the liquidity ratio of EUROFINS MICROBIOLOGIE FR... (750.16) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
-13186.39x2024
2022
2023
2024
Q1: -45.56x
Med: 0.0x
Q3: 2.85x
Average
In 2024, the interest coverage of EUROFINS MICROBIOLOGIE FR... (-13186.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 58 days. Excellent situation: suppliers finance 58 days of the operating cycle (retail model).
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
58 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2021
2022
2023
2024
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
0
0
Customer payment term (days)
0
0
0
0
0
0
0
0
Supplier payment term (days)
12
108
15
79
-1740
52
101
58
Positioning of EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS in its sector
Comparison with sector Activités des sièges sociaux
Similar companies (Activités des sièges sociaux)
Compare EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS with other companies in the same sector:
Frequently asked questions about EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS
What is the revenue of EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS ?
The revenue of EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS is not publicly disclosed (confidential accounts filed with INPI).
Is EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS profitable?
EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS recorded a net loss in 2024.
Where is the headquarters of EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS ?
The headquarters of EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS is located in NANTES (44300), in the department Loire-Atlantique.
Where to find the tax return of EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS ?
The tax return of EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS operate?
EUROFINS MICROBIOLOGIE FRANCE HOLDING SAS operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart